Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Horizon Therapeutics Denmark ApS
APS
Dissolved
Advertising protection
CVR 43478060
Sundkrogsgade 21, 2100
København Ø
Business and other management consultancy activities
·
NACE 7020
Est. 2022 · 3 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Business and other management consultancy activities
/
Horizon Therapeutics Denmark ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (5)
KL
Karin Louise Ulrika Järperud
Management
Management
2023 – 2025
PF
Paraskevi Florou
Management
Management
2023 – 2025
HT
Horizon Therapeutics Ireland DAC
Founder
Founder
2022 – 2025
Tv
Tore von Würden Petersen
Management
Management
2023 – 2025
PP
Patrick Paul McIlvenny
Chief Executive Officer
Chief Executive Officer
2022 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Former (6)
KL
Karin Louise Ulrika Järperud
Board of Directors
Board of Directors
2023 – 2025
PF
Paraskevi Florou
Board of Directors
Board of Directors
2023 – 2025
WD
William David Gannon
Board of Directors
Board of Directors
2022 – 2023
DJ
David James Caraher
Board of Directors
Board of Directors
2022 – 2023
Tv
Tore von Würden Petersen
Chairman
Chairman
2023 – 2025
PP
Patrick Paul McIlvenny
Chairman
Chairman
2022 – 2023
Shareholders
As of last annual report
Horizon Therapeutics Ireland DAC — 100%
100%
Shareholder
Type
Ownership
Votes
Since
Horizon Therapeutics Ireland DAC
Individual
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Horizon Therapeutics Denmark ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
